Sartorius Stedim Biotech Extends PAT Portfolio with Innovative Sensors for Flow Rate Measurement
Sartorius Stedim Biotech (SSB) has entered into a global development co-operation agreement with the flow measurement company em-tec. This highly specialized firm provides non-invasive flow engineering solutions for blood vessels and flexible tubing. Such technology designed by em-tec is used in the biopharmaceutical industry, among other sectors, in many process steps for accurate measurement of flow rates and mass balances. In particular, this technology is used in downstream processes, such as virus inactivation, as well as in ultrafiltration and diafiltration.
As part of this co-operation, the technology base of em-tec will be extended by jointly developed single-use components, such as FlowTube. Sartorius will exclusively market these as applications and distribute them worldwide as private label products under the brand name of BioPAT Flow.
SSB has continuously expanded its process analytics portfolio over the past years in the area of sensor technology to enable non-invasive, real-time measurement of critical process parameters, such as pH, dissolved oxygen, temperature, glucose, lactate and biomass. The new flow sensors are important new components that have been added to this portfolio. BioPAT Flow permits precise, reproducible data to be collected on flow rates and mass balances without coming in contact with the medium during measurement.
“The sensors make our downstream unit operations even more intelligent, significantly increasing the level of automation. Integrated into our system solutions, these sensors are powerful tools for designing robust biopharmaceutical processes and further optimizing them,” states Stefan Schlack, Senior Vice President of Marketing at SSB.
Dr Hannspeter Schubert, managing director of em-tec, comments: “SSB is among the top global suppliers in automated bioprocess solutions and has a strong globally based sales and marketing network. We are pleased that Sartorius has opted for our basic technology of non-invasive flow rate measurement. The use of our sensors in fully integrated, automated bioprocesses represents an ideal application field and an innovative technological advance for us.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance